Recursion Pharmaceuticals Inc (NASDAQ: RXRX) Hogging The Spotlight Today
Currently, there are 226.26M common shares owned by the public and among those 169.56M shares have been available to trade. The company’s stock has a 5-day price change of -15.25% and -24.77% over the past three months. RXRX shares are trading -23.94% year to date (YTD), with the 12-month market performance down to -0.66% lower. […]
Recursion Pharmaceuticals Inc (RXRX): A Great Stock For Handling Current Market Conditions?
Currently, there are 226.26M common shares owned by the public and among those 169.55M shares have been available to trade. The company’s stock has a 5-day price change of 0.86% and -10.96% over the past three months. RXRX shares are trading -5.27% year to date (YTD), with the 12-month market performance up to 21.14% higher. […]
An Important Check-Up On Recursion Pharmaceuticals Inc (NASDAQ: RXRX)
Recursion Pharmaceuticals Inc (RXRX) concluded trading on Tuesday at a closing price of $9.70, with 4.45 million shares of worth about $43.12 million changed hands on the day. On June 18, 2024 the price saw a gain of about 3.52%. Currently the company’s common shares owned by public are about 226.26M shares, out of which, […]
Recursion Pharmaceuticals Inc (RXRX) Testing Investors’ Patience Right Now
Currently, there are 183.21M common shares owned by the public and among those 146.52M shares have been available to trade. Insiders at the company have transacted a total of 136 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 56 of these insider trades were purchases, […]
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) – Suitable For Long Term Buy?
Currently, there are 183.21M common shares owned by the public and among those 151.91M shares have been available to trade. Insiders at the company have transacted a total of 143 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 61 of these insider trades were purchases, […]
Now Is A Suitable Moment For A Long-Term Purchase Of Recursion Pharmaceuticals Inc (NASDAQ: RXRX)
Currently, there are 183.21M common shares owned by the public and among those 151.89M shares have been available to trade. Insiders at the company have transacted a total of 153 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 65 of these insider trades were purchases, […]
Recursion Pharmaceuticals Inc (NASDAQ: RXRX): Reassessing Prospects
Recursion Pharmaceuticals Inc (RXRX) concluded trading on Thursday at a closing price of $9.90, with 4.24 million shares of worth about $41.99 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -9.75% during that period and on Thursday the price saw a gain of […]
Stick With Recursion Pharmaceuticals Inc (RXRX). The Bull Are Alive And Well
ARK Investment Management LLC recently announced the acquisition of new stake in Recursion Pharmaceuticals Inc (NASDAQ:RXRX). The institutional investor has increased its shareholding in the Healthcare company by 200.36% to 20.65 million shares with purchase of 13.78 million shares. This fresh investment now brings its stake to 9.92% valued currently at $203.65 million. In addition, […]
Stick With Recursion Pharmaceuticals Inc (RXRX). The Bull Are Alive And Well
The Vanguard Group, Inc. recently announced the acquisition of new stake in Recursion Pharmaceuticals Inc (NASDAQ:RXRX). The institutional investor has increased its shareholding in the Healthcare company by 38.41% to 15.27 million shares with purchase of 4.24 million shares. This fresh investment now brings its stake to 7.33% valued currently at $104.6 million. In addition, […]
Recursion Pharmaceuticals Inc (NASDAQ: RXRX): To Buy Or Not To Buy, That Is The Question
The Vanguard Group, Inc. has recently announced that it has increased stake in Recursion Pharmaceuticals Inc (NASDAQ:RXRX) by 38.41%. After grabbing 15.27 million shares, the institutional investor is now in possession of 4.24 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 7.33% having worth around $104.6 million. […]
